1-20 of 2,079 results for tabledby:"Ed Davey"
Librarians' tools
- Search time
- 0.619 seconds
- Solr query time
- 0.009 seconds
- Search query
- tabledby:"Ed Davey"
- We searched for
- tablingMember_ses:300030
Type
House
Session
Year
Department
More
Member
More
Primary member
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Work and Pensions, when he plans to provide an update on the progress in the implementation of his Department's response to the Independent Review into Carer’s Allowance Overpayments to the (a) Public Accounts and (b) Work and Pensions Committees.
To ask the Secretary of State for Work and Pensions, when he plans to provide an update on the progress in the implementation of his Department's response to the Independent Review into Carer’s Allowance Overpayments to the (a) Public Accounts and (b) Work and Pensions Committees.
It has not proved possible to respond to the Rt hon. Member in the time available before Prorogation.
To ask the Secretary of State for Work and Pensions, if he will publish the two outstanding recommendations from the Independent Review into Carer’s Allowance Overpayments which have not been accepted by his Department.
To ask the Secretary of State for Work and Pensions, if he will publish the two outstanding recommendations from the Independent Review into Carer’s Allowance Overpayments which have not been accepted by his Department.
It has not proved possible to respond to the Rt hon. Member in the time available before Prorogation.
To ask the Secretary of State for Work and Pensions, if he will publish a copy of the (a) written and (b) SMS correspondence sent to people when the Department requires further information to reassess their Carer's Allowance case.
To ask the Secretary of State for Work and Pensions, if he will publish a copy of the (a) written and (b) SMS correspondence sent to people when the Department requires further information to reassess their Carer's Allowance case.
It has not proved possible to respond to the Rt hon. Member in the time available before Prorogation.
That this House notes with alarm the impact of President Trump’s war with Iran on fuel prices and transport costs for people across the United Kingdom, with petrol up by 25p per litre and diesel up by 48p per litre since the war began; further notes that Government revenues from taxes on fossil fuels are significantly higher than expected due to the war; and calls on the Government to use that extra revenue to introduce an emergency transport package to help families and businesses with the cost of travel, including an immediate 10p cut in fuel duty, a reduction in the cap on bus fares to £1, a 10% cut in rail fares, a cut in VAT on public electric vehicle charging to 5%, and a review of the network costs that push up charging prices.
That this House notes with alarm the impact of President Trump’s war with Iran on fuel prices and transport costs for people across the United Kingdom, with petrol up by 25p per litre and diesel up by 48p per litre since the war began; further notes that Government revenues from...
That this House notes with concern reports regarding the conduct of Sir Robbie Gibb in his capacity as a member of the BBC Board; recognises the importance of maintaining the Corporation's independence and the confidence of the public in its governance and editorial processes; observes that there have been claims of Gibb's involvement in recruitment matters and editorial discussions that may have given rise to perceptions of partiality; further notes concerns that alleged delays precipitated by Gibb in addressing issues arising from the 2021 Panorama documentary created uncertainty about the Corporation's position; acknowledges that questions have been raised about the processes leading to certain senior appointments; considers that public trust in the BBC's impartiality depends on transparent and independent governance; believes that the impartiality of future appointments cannot be assured while he remains on the Board; and therefore calls upon the Government to remove Sir Robbie Gibb from his current position and to ensure that all future BBC Board appointments are conducted entirely independently of political influence.
That this House notes with concern reports regarding the conduct of Sir Robbie Gibb in his capacity as a member of the BBC Board; recognises the importance of maintaining the Corporation's independence and the confidence of the public in its governance and editorial processes; observes that there have been claims...
That this House notes with grave concern the actions of Elon Musk in inciting violence and attempting to subvert our democracy at Tommy Robinson’s Unite the Kingdom rally; further notes that such actions risk legitimising extremism, undermining community cohesion and threatening public safety; believes that individuals who enable or encourage divisive and inflammatory activity should be held to account for their conduct; further believes that all individuals who use their platforms to spread or endorse harmful and divisive content should be held to account; recognises that no person, regardless of wealth or power, should be allowed to use their platform to inflame tensions or incite violence; and therefore demands that Elon Musk be summoned to appear at the Bar of the House of Commons to be reprimanded and publicly admonished for his conduct.
That this House notes with grave concern the actions of Elon Musk in inciting violence and attempting to subvert our democracy at Tommy Robinson’s Unite the Kingdom rally; further notes that such actions risk legitimising extremism, undermining community cohesion and threatening public safety; believes that individuals who enable or encourage...
That, given the ongoing humanitarian catastrophe taking place in Gaza, the ongoing captivity of hostages by Hamas, and the planned expansion of the Israeli military's operations into Gaza City, an humble Address be presented to His Majesty that he will be graciously pleased to give directions that there be laid before this House, no later than 1 November, any legal advice held or provided by the Attorney General relating to whether there have been breaches of international law in the Israel-Gaza war (2023 to present).
That, given the ongoing humanitarian catastrophe taking place in Gaza, the ongoing captivity of hostages by Hamas, and the planned expansion of the Israeli military's operations into Gaza City, an humble Address be presented to His Majesty that he will be graciously pleased to give directions that there be laid...
That this House expresses its condemnation of the Israeli government's expansion of military activity in Gaza and declaration of 22 new settlements in the West Bank; denounces Prime Minister Netanyahu's unwillingness to comprehensively lift the devastating aid blockade; rejects as dangerous, insufficient and unworkable the operation of the Gaza Humanitarian Foundation; calls on the Government to develop an alternative plan with other countries to take aid into the Strip through a humanitarian corridor, ideally sponsored by the UN; believes that Hamas should immediately and unconditionally release the remaining 58 hostages; notes that military action will not support getting the remaining hostages back to Israel, and that only diplomacy has been the consistently effective tool through which those in Hamas’ captivity have made it home; urges the Government to immediately sanction Ministers Ben-Gvir, Smotrich and Katz, who consistently call for the dispossession of Palestinians, and to immediately ban all UK arms exports to Israel; urges the Government to immediately suspend the 2030 roadmap for UK-Israel bilateral relations, until the humanitarian catastrophe in Gaza is alleviated; calls on the Government, in lieu of imminent action by the Israeli government to allow full aid access to Gaza and draw back its military campaign, to expand sanctions to Israeli Ministers and Members of the Knesset who support continuing the blockade and military action; and urges the Government to recognise the state of Palestine, showing beyond doubt the UK’s commitment to Palestinians’ right to self-determination and a two-state solution as the only just, political settlement.
That this House expresses its condemnation of the Israeli government's expansion of military activity in Gaza and declaration of 22 new settlements in the West Bank; denounces Prime Minister Netanyahu's unwillingness to comprehensively lift the devastating aid blockade; rejects as dangerous, insufficient and unworkable the operation of the Gaza Humanitarian...
That an humble Address be presented to His Majesty, that he will be graciously pleased to give directions that there be deposited in the Library of the House of Commons all impact assessments which His Majesty’s Government has made regarding the impact of potential US tariffs on the UK economy.
That an humble Address be presented to His Majesty, that he will be graciously pleased to give directions that there be deposited in the Library of the House of Commons all impact assessments which His Majesty’s Government has made regarding the impact of potential US tariffs on the UK economy.
That this House has no confidence in His Majesty's Government.
That this House has no confidence in His Majesty's Government.
To ask the Secretary of State for Health and Social Care, how much funding her Department has provided for research into (a) prevention and (b) the treatment of cancer in each of the last 12 years.
To ask the Secretary of State for Health and Social Care, how much funding her Department has provided for research into (a) prevention and (b) the treatment of cancer in each of the last 12 years.
The Department invests over £1 billion per year in health research through the National Institute for Health Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23.
When categorising prevention and treatment, the Department and NIHR uses the Health Research Classification System (HRCS) Health Category coding, which was developed by the UK Clinical Research Collaboration (UKCRC) Partners and was designed to produce a broad strategic overview of health research funding.
The NIHR have funded 127 projects on cancer prevention for the period April 2012 to date with a combined total funding value of approximately £90.3 million:
F/Y | Funded projects | Funding Amount |
2012/13 | 7 | £3,735,044 |
2013/14 | 8 | £2,858,223 |
2014/15 | 16 | £7,281,782 |
2015/16 | 12 | £9,206,926 |
2016/17 | 8 | £3,503,717 |
2017/18 | 26 | £25,467,753 |
2018/19 | 8 | £5,428,968 |
2019/20 | 10 | £12,099,536 |
2020/21 | 8 | £4,346,694 |
2021/22 | 12 | £8,892,741 |
2022/23 | 12 | £7,529,430 |
total | 127 | £90,350,814 |
The NIHR have funded 685 projects on cancer treatment for the period April 2012 to date with a combined total funding value of approximately £302.4 million:
F/Y | Funded projects | Funding Amount |
2012/13 | 56 | £23,937,981 |
2013/14 | 44 | £19,765,569 |
2014/15 | 53 | £27,226,212 |
2015/16 | 54 | £26,887,042 |
2016/17 | 70 | £19,930,361 |
2017/18 | 62 | £22,760,373 |
2018/19 | 52 | £18,283,962 |
2019/20 | 66 | £18,683,770 |
2020/21 | 76 | £35,330,181 |
2021/22 | 90 | £55,518,331 |
2022/23 | 62 | £34,115,891 |
total | 685 | £302,439,673 |
The NIHR Infrastructure investment funds the world-class facilities, expertise, and skilled delivery workforce for research across the National Health Service and wider health and care system in England from early translational clinical research through to applied health and care research. It is difficult to attribute this funding to specific disease and therapy areas as the staff and facilities funded through the NIHR Infrastructure supports research across disciplines.
To ask the Secretary of State for Health and Social Care, whether she has held recent discussions with (a) ADHD UK, (b) the ADHD Foundation and (c) other organisations representing people with ADHD.
To ask the Secretary of State for Health and Social Care, whether she has held recent discussions with (a) ADHD UK, (b) the ADHD Foundation and (c) other organisations representing people with ADHD.
Ministerial meetings with external stakeholders are routinely published on GOV.UK on a quarterly basis.
To ask the Secretary of State for Health and Social Care, what support her Department is offering to patients unable to access medication for ADHD.
To ask the Secretary of State for Health and Social Care, what support her Department is offering to patients unable to access medication for ADHD.
We are aware of disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) including lisdexamfetamine and methylphenidate, primarily driven by issues which have resulted in capacity constraints at key manufacturing sites.
We have issued communications to the National Health Service to advise healthcare professionals on management of patients whilst there continue to be disruptions to supplies. Patients are advised to speak to their clinician regarding any concerns they have and to discuss the suitability of treatment with alternative medicines where necessary.
We understand how frustrating and distressing medicine shortages can be. We are working with the respective manufacturers to resolve the issues as soon as possible and meet with them very regularly to help ensure that action is taken to improve the availability of ADHD medicines in the United Kingdom, in the short, medium, and long term.
To ask the Secretary of State for Health and Social Care, what steps she plans to take to increase the supply of (a) Lisdexamfetamine, (b) Methylphenidate and (c) other ADHD medication.
To ask the Secretary of State for Health and Social Care, what steps she plans to take to increase the supply of (a) Lisdexamfetamine, (b) Methylphenidate and (c) other ADHD medication.
We are aware of disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) including lisdexamfetamine and methylphenidate, primarily driven by issues which have resulted in capacity constraints at key manufacturing sites.
We have issued communications to the National Health Service to advise healthcare professionals on management of patients whilst there continue to be disruptions to supplies. Patients are advised to speak to their clinician regarding any concerns they have and to discuss the suitability of treatment with alternative medicines where necessary.
We understand how frustrating and distressing medicine shortages can be. We are working with the respective manufacturers to resolve the issues as soon as possible and meet with them very regularly to help ensure that action is taken to improve the availability of ADHD medicines in the United Kingdom, in the short, medium, and long term.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the availability of ADHD medication; and whether her Department has held recent discussions with relevant stakeholders on the availability of ADHD medication.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the availability of ADHD medication; and whether her Department has held recent discussions with relevant stakeholders on the availability of ADHD medication.
We are aware of disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) including lisdexamfetamine and methylphenidate, primarily driven by issues which have resulted in capacity constraints at key manufacturing sites.
We have issued communications to the National Health Service to advise healthcare professionals on management of patients whilst there continue to be disruptions to supplies. Patients are advised to speak to their clinician regarding any concerns they have and to discuss the suitability of treatment with alternative medicines where necessary.
We understand how frustrating and distressing medicine shortages can be. We are working with the respective manufacturers to resolve the issues as soon as possible and meet with them very regularly to help ensure that action is taken to improve the availability of ADHD medicines in the United Kingdom, in the short, medium, and long term.
That this House condemns the awful terrorist attacks carried out by Hamas in Israel on the 7th October; notes with utter dismay the scenes of violence in the weeks and days since; further notes with deep concern the devastating situation in Gaza which is on the verge of a humanitarian crisis for its 2.2 million residents and that over 200 Israelis are being held hostage; urges the UK Government to lead international efforts to call for the restoration of essential supplies such as food, water, medicine and electricity to Gaza in line with international law; further urges the UK Government to heed the calls of the World Health Organization, that the forced evacuation of hospitals in Northern Gaza may be a breach of international humanitarian law; affirms that Israel has a right to protect its citizens and target Hamas in line with international law; further affirms that innocent Palestinians must not pay the price for the atrocities of Hamas; accordingly urges the UK Government to lead calls for an immediate humanitarian ceasefire as a pause in hostilities which will facilitate the delivery of humanitarian aid into Gaza and provide an opportunity to realise the release of the hostages; further believes that the people of Israel and Palestine have a right to live free from fear; and that accordingly the UK Government must redouble efforts to bring about a lasting peace and a two state solution.
That this House condemns the awful terrorist attacks carried out by Hamas in Israel on the 7th October; notes with utter dismay the scenes of violence in the weeks and days since; further notes with deep concern the devastating situation in Gaza which is on the verge of a humanitarian...
To ask the Secretary of State for Health and Social Care, how many and what proportion of NHS cancer patients have waited longer than (a) 62 days, (b) 3 months, (c) 4 months, (d) 6 months and (e) 12 months in each of the last three years.
To ask the Secretary of State for Health and Social Care, how many and what proportion of NHS cancer patients have waited longer than (a) 62 days, (b) 3 months, (c) 4 months, (d) 6 months and (e) 12 months in each of the last three years.
The following table shows the number of first treatments following an urgent suspected cancer referral, and the proportion that waited longer than the specified time:
Number of patients treated who waited | 2020/21 | 2021/22 | 2022/23 |
Over 62 days | 38,083 (26%) | 53,112 (31%) | 70,929 (39%) |
Over 3 months (>90 days) | 16,084 (11%) | 22,323 (13%) | 33,652 (18%) |
Over 4 months (>124 days) | 5,723 (4%) | 7,117 (4%) | 12,343 (7%) |
Over 6 months (>182 days) | 1,339 (1%) | 1,181 (1%) | 2,252 (1%) |
Over 12 months (>365 days) | 18 (0.01%) | 28 (0.02%) | 42 (0.02%) |
Total Treated | 148,280 | 171,395 | 182,454 |
Information on the number of people with an urgent referral waiting to start cancer treatment is not held in the format requested. Monthly information is published on the backlog of patients waiting longer than 62 days from urgent general practitioner referral for suspected cancer. This shows that there were 3,344 patients waiting past day 62 following an urgent suspected cancer referral with a decision to treat.
We are unable to publicly disclose the longest wait for a patient to start cancer treatment on the National Health Service for each of the last three years as we cannot provide information which could be patient-identifiable, in line with established disclosure controls.
To ask the Secretary of State for Health and Social Care, how many people with an urgent referral are waiting to start cancer treatment on the NHS.
To ask the Secretary of State for Health and Social Care, how many people with an urgent referral are waiting to start cancer treatment on the NHS.
The following table shows the number of first treatments following an urgent suspected cancer referral, and the proportion that waited longer than the specified time:
Number of patients treated who waited | 2020/21 | 2021/22 | 2022/23 |
Over 62 days | 38,083 (26%) | 53,112 (31%) | 70,929 (39%) |
Over 3 months (>90 days) | 16,084 (11%) | 22,323 (13%) | 33,652 (18%) |
Over 4 months (>124 days) | 5,723 (4%) | 7,117 (4%) | 12,343 (7%) |
Over 6 months (>182 days) | 1,339 (1%) | 1,181 (1%) | 2,252 (1%) |
Over 12 months (>365 days) | 18 (0.01%) | 28 (0.02%) | 42 (0.02%) |
Total Treated | 148,280 | 171,395 | 182,454 |
Information on the number of people with an urgent referral waiting to start cancer treatment is not held in the format requested. Monthly information is published on the backlog of patients waiting longer than 62 days from urgent general practitioner referral for suspected cancer. This shows that there were 3,344 patients waiting past day 62 following an urgent suspected cancer referral with a decision to treat.
We are unable to publicly disclose the longest wait for a patient to start cancer treatment on the National Health Service for each of the last three years as we cannot provide information which could be patient-identifiable, in line with established disclosure controls.
To ask the Secretary of State for Health and Social Care, what was the single longest wait for a patient to start cancer treatment on the NHS for each of the last three years.
To ask the Secretary of State for Health and Social Care, what was the single longest wait for a patient to start cancer treatment on the NHS for each of the last three years.
The following table shows the number of first treatments following an urgent suspected cancer referral, and the proportion that waited longer than the specified time:
Number of patients treated who waited | 2020/21 | 2021/22 | 2022/23 |
Over 62 days | 38,083 (26%) | 53,112 (31%) | 70,929 (39%) |
Over 3 months (>90 days) | 16,084 (11%) | 22,323 (13%) | 33,652 (18%) |
Over 4 months (>124 days) | 5,723 (4%) | 7,117 (4%) | 12,343 (7%) |
Over 6 months (>182 days) | 1,339 (1%) | 1,181 (1%) | 2,252 (1%) |
Over 12 months (>365 days) | 18 (0.01%) | 28 (0.02%) | 42 (0.02%) |
Total Treated | 148,280 | 171,395 | 182,454 |
Information on the number of people with an urgent referral waiting to start cancer treatment is not held in the format requested. Monthly information is published on the backlog of patients waiting longer than 62 days from urgent general practitioner referral for suspected cancer. This shows that there were 3,344 patients waiting past day 62 following an urgent suspected cancer referral with a decision to treat.
We are unable to publicly disclose the longest wait for a patient to start cancer treatment on the National Health Service for each of the last three years as we cannot provide information which could be patient-identifiable, in line with established disclosure controls.
To ask the Secretary of State for Health and Social Care, how many people are receiving cancer treatment on the NHS.
To ask the Secretary of State for Health and Social Care, how many people are receiving cancer treatment on the NHS.
The latest published data shows that the total number of patients who received their first or subsequent treatment in June 2023 was 54,112.